Hamilton Thorne Ltd (HTLZF) 0.2820 $HTLZF
Hamilton Thorne Announces Availability of Oosight(R) Product Line
Marketwire Canada - Mon Apr 06, 3:20PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that the Company now offers the Oosight(R) product line, which it has acquired from Cambridge Research & Instrumentation, Inc. (CRi).
HTL.VN: 0.400 (unch)
Hamilton Thorne Announces Record Revenue and Net Income for the Quarter and Year Ended December 31, 2014
Marketwire Canada - Wed Feb 11, 8:22AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year-ended December 31, 2014.
HTL.VN: 0.400 (unch)
Hamilton Thorne Releases Easy to Use and Cost-Effective Remote Capture CASA System
Marketwire Canada - Mon Jan 05, 4:10PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the commercial release of its easy to use and cost-effective Remote Capture station for its industry-leading Computer Assisted Sperm Analysis (CASA) systems.
HTL.VN: 0.400 (unch)
Hamilton Thorne Announces Record Third Quarter and Nine-Month Sales and Net Income
Marketwired - Tue Nov 25, 7:03AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the third quarter and nine-month period ended September 30, 2014.
HTL.VN: 0.400 (unch)
Hamilton Thorne Comments on Unusual Market Activity
Marketwired - Wed Nov 19, 2:53PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported that, in view of the unusual market activity in the common shares of the Company, the Investment Industry Regulatory Organization of Canada (IIROC) has contacted the Company in accordance with its usual practice. While it ordinarily does not comment on market activity or market rumors, the Company confirmed that it is not aware of any material corporate developments that could account for the unusual trading activity.
HTL.VN: 0.400 (unch)
Hamilton Thorne Announces Initial Closing of Over-Subscribed CDN$750,000 Private Placement
Marketwire Canada - Tue Nov 11, 3:45PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"
, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the initial closing of its previously announced non-brokered private placement.
HTL.VN: 0.400 (unch)
Hamilton Thorne Announces Private Placement Unit Offering of Up to CDN$750,000
Marketwire Canada - Wed Oct 22, 3:33PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company", a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it is proposing to issue, on a non-brokered private placement basis, an aggregate of up to 7,500,000 Units ("Units) at an offering price of CDN$0.10 per Unit for aggregate gross proceeds of up to approximately CDN$750,000 (subject to increase at the discretion of the board of directors) (the "Offering". Each Unit will consist of one common share (each, a "Common Share" of the Company and one common share purchase warrant (each, a "Warrant". Each Warrant will provide the holder the right to purchase a Common Share at CDN$0.20 for a period of twelve months following the closing (subject to acceleration in certain circumstances at the Company's sole discretion).
HTL.VN: 0.400 (unch)
Hamilton Thorne Announces New CASA Products at 2014 American Society for Reproductive Medicine Meeting
Marketwire Canada - Tue Oct 21, 1:26PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced a number of product releases at the annual American Society for Reproductive Medicine meeting being held in Honolulu, Hawaii from October 18 to October 22, 2014.
HTL.VN: 0.400 (unch)
Hamilton Thorne Announces Record Second Quarter Sales and Fourth Consecutive Quarter of Net Income
Marketwire - Wed Aug 27, 3:16PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the second quarter and six month period ended June 30, 2014.
HTL.VN: 0.400 (unch)
Hamilton Thorne Receives Notification of Grant of Patent Right and CFDA Approval to Market Its LYKOS(R) Laser System in China
Marketwire Canada - Wed Jul 16, 7:20AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has received notice that the China Food and Drug Administration (CFDA) has approved the Company's cutting edge LYKOS(R) for sale to clinical markets in China. Concurrent to this, the Company is pleased to announce it has received a Notification to Grant Patent Right for Invention covering the Modular Laser Assembly that is at the heart of its LYKOS system.
HTL.VN: 0.400 (unch)
Hamilton Thorne Announces Availability of Oosight(R) Product Line
Marketwire Canada - Mon Apr 06, 3:20PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that the Company now offers the Oosight(R) product line, which it has acquired from Cambridge Research & Instrumentation, Inc. (CRi).
HTL.VN: 0.400 (unch)
Hamilton Thorne Announces Record Revenue and Net Income for the Quarter and Year Ended December 31, 2014
Marketwire Canada - Wed Feb 11, 8:22AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year-ended December 31, 2014.
HTL.VN: 0.400 (unch)
Hamilton Thorne Releases Easy to Use and Cost-Effective Remote Capture CASA System
Marketwire Canada - Mon Jan 05, 4:10PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the commercial release of its easy to use and cost-effective Remote Capture station for its industry-leading Computer Assisted Sperm Analysis (CASA) systems.
HTL.VN: 0.400 (unch)
Hamilton Thorne Announces Record Third Quarter and Nine-Month Sales and Net Income
Marketwired - Tue Nov 25, 7:03AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the third quarter and nine-month period ended September 30, 2014.
HTL.VN: 0.400 (unch)
Hamilton Thorne Comments on Unusual Market Activity
Marketwired - Wed Nov 19, 2:53PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported that, in view of the unusual market activity in the common shares of the Company, the Investment Industry Regulatory Organization of Canada (IIROC) has contacted the Company in accordance with its usual practice. While it ordinarily does not comment on market activity or market rumors, the Company confirmed that it is not aware of any material corporate developments that could account for the unusual trading activity.
HTL.VN: 0.400 (unch)
Hamilton Thorne Announces Initial Closing of Over-Subscribed CDN$750,000 Private Placement
Marketwire Canada - Tue Nov 11, 3:45PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"
, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the initial closing of its previously announced non-brokered private placement. HTL.VN: 0.400 (unch)
Hamilton Thorne Announces Private Placement Unit Offering of Up to CDN$750,000
Marketwire Canada - Wed Oct 22, 3:33PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"
, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it is proposing to issue, on a non-brokered private placement basis, an aggregate of up to 7,500,000 Units ("Units) at an offering price of CDN$0.10 per Unit for aggregate gross proceeds of up to approximately CDN$750,000 (subject to increase at the discretion of the board of directors) (the "Offering". Each Unit will consist of one common share (each, a "Common Share" of the Company and one common share purchase warrant (each, a "Warrant". Each Warrant will provide the holder the right to purchase a Common Share at CDN$0.20 for a period of twelve months following the closing (subject to acceleration in certain circumstances at the Company's sole discretion). HTL.VN: 0.400 (unch)
Hamilton Thorne Announces New CASA Products at 2014 American Society for Reproductive Medicine Meeting
Marketwire Canada - Tue Oct 21, 1:26PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced a number of product releases at the annual American Society for Reproductive Medicine meeting being held in Honolulu, Hawaii from October 18 to October 22, 2014.
HTL.VN: 0.400 (unch)
Hamilton Thorne Announces Record Second Quarter Sales and Fourth Consecutive Quarter of Net Income
Marketwire - Wed Aug 27, 3:16PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the second quarter and six month period ended June 30, 2014.
HTL.VN: 0.400 (unch)
Hamilton Thorne Receives Notification of Grant of Patent Right and CFDA Approval to Market Its LYKOS(R) Laser System in China
Marketwire Canada - Wed Jul 16, 7:20AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has received notice that the China Food and Drug Administration (CFDA) has approved the Company's cutting edge LYKOS(R) for sale to clinical markets in China. Concurrent to this, the Company is pleased to announce it has received a Notification to Grant Patent Right for Invention covering the Modular Laser Assembly that is at the heart of its LYKOS system.
HTL.VN: 0.400 (unch)
